PLK4 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PLK4 monoclonal antibodies for research in cell cycle regulation and mitotic processes. PLK4 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PLK4, or Polo-like kinase 4, plays a critical role in centriole biogenesis and is essential for proper cell division. Dysregulation of PLK4 has been implicated in various cancers, making it a significant target for therapeutic intervention and a key focus in cancer research. Understanding PLK4 function can provide insights into the mechanisms of tumorigenesis and potential strategies for treatment. Researchers worldwide utilize PLK4 monoclonal antibodies to investigate cellular division mechanisms and their relationship to cancer development. The high specificity of PLK4 monoclonal antibodies enables precise detection and analysis of protein expression patterns in diverse experimental settings. Santa Cruz Biotechnology monoclonal antibodies for PLK4 support researchers in advancing our understanding of cell cycle regulation and contributing to breakthrough discoveries in cancer biology.